Drug Type Small molecule drug |
Synonyms- |
Target |
Action partial agonists |
Mechanism PPARα partial agonists(Peroxisome proliferator-activated receptor α partial agonists), PPARγ partial agonists(Peroxisome proliferator-activated receptor γ partial agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H20O3 |
InChIKeyUDWUKDKWHIAYOW-DEOSSOPVSA-N |
CAS Registry3076938-60-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | Italy | 05 Sep 2024 |





